Polarized hepatocytes expressing hyperactive Ha-Ras adopt an invasive and metastatic phenotype in cooperation with transforming growth factor (TGF)-b. This dramatic increase in malignancy is displayed by an epithelial to mesenchymal transition (EMT), which mimics the TGFb-mediated progression of human hepatocellular carcinomas. In culture, hepatocellular EMT occurs highly synchronously, facilitating the analysis of molecular events underlying the various stages of this process. Here, we show that in response to TGF-b, phosphorylated Smads rapidly translocated into the nucleus and activated transcription of target genes such as E-cadherin repressors of the Snail superfamily, causing loss of cell adhesion. Within the TGF-b superfamily of cytokines, TGF-b1, -b2 and -b3 were specific for the induction of hepatocellular EMT. Expression profiling of EMT kinetics revealed 78 up-and 235 downregulated genes, which preferentially modulate metabolic activities, extracellular matrix composition, transcriptional activities and cell survival. Independent of the genetic background, platelet-derived growth factor (PDGF)-A ligand and both PDGF receptor subunits were highly elevated, together with autocrine secretion of bioactive PDGF. Interference with PDGF signalling by employing hepatocytes expressing the dominant-negative PDGF-a receptor revealed decreased TGF-b-induced migration in vitro and efficient suppression of tumour growth in vivo. In conclusion, these results provide evidence for a crucial role of PDGF in TGF-bmediated tumour progression of hepatocytes and suggest PDGF as a target for therapeutic intervention in liver cancer.
Introduction
Carcinomas represent the most frequent malignant diseases in the world. Multiple mutations contributing to malignant transformation of epithelial cells have been described and characterized for a variety of tumour types (Hanahan and Weinberg, 2000) , but the involvement of such mutated genes to local invasiveness and metastasis remains less well understood.
Epithelial to mesenchymal transition (EMT) is a fundamental process during normal development, inflammation and wound healing. Increasing evidences indicate that EMT represents an in vivo correlate to late stages of carcinoma progression (Boyer et al., 2000; Thiery, 2002; Grunert et al., 2003; Gotzmann et al., 2004) . During EMT, polarized epithelial cells acquire a fibroblastoid phenotype, display increased motility and an enhanced invasive potential. These alterations are reminiscent of metastatic processes, when tumour cells leave well-organized epithelial structures to migrate to distal locations. Cells undergoing EMT typically lose cell-cell adhesion molecules, change the expression pattern of cell surface molecules such as integrins and show extensive alterations of the extracellular matrix (ECM) composition, including secretion of ECM-remodelling enzymes of the matrix metalloproteinase (MMP) family. Downregulation of the tumour suppressor Ecadherin represents a pivotal event associated with the onset of epithelial dedifferentiation, which contributes to enhanced cell motility and invasiveness and thus correlates with poor prognosis of a variety of carcinomas (Frixen et al., 1991; Vleminckx et al., 1991; Behrens et al., 1992; Perl et al., 1998; Conacci-Sorrell et al., 2002) . The expression of E-cadherin is controlled by transcriptional repressors of the Snail superfamily (Hajra et al., 2002; Nieto, 2002) , which include the Smad-interacting protein SIP1 (Comijn et al., 2001) , the basic HLH-protein E12/ E47 (Perez-Moreno et al., 2001) and the E-box-binding transcription factor delta-EF1/ZEB (Grooteclaes and Frisch, 2000; Eger et al., 2005) . It was shown that ectopic overexpression of Snail in different epithelial cells was sufficient to cause a phenotypical conversion to fibroblastoid cells, which was accompanied by loss of Ecadherin expression and acquisition of tumorigenic and invasive properties (Cano et al., 2000) .
We have recently established a cellular EMT model unique to hepatocytes that is driven by the collaboration of hyperactive Ras and transforming growth factor (TGF)-b (Gotzmann et al., 2002) , a functional synergy also described in breast epithelial cells (Oft et al., 1996; Janda et al., 2002) . TGF-b signals through a heteromeric pair of TGF-b receptors (TbRs), which phosphorylate intracellular adaptor molecules known as Smads. Upon their nuclear translocation, Smad complexes regulate the transcription of a set of target genes, leading to various changes in the cellular phenotype. On the one hand, TGF-b exhibits a tumour-suppressive function since it acts as a potent inhibitor of epithelial cell proliferation by arresting cells in the G1 phase of the cell cycle and by inducing apoptosis (Reynisdottir et al., 1995) . In several cancer types, the negative interference of this pathway by mutations that lead to nonfunctional Smad4 or TbRs underscores the tumour-suppressive potential of TGF-b. On the other hand, TGF-b can act in a tumour-promoting manner, particularly if cooperating with other oncogenes (de Caestecker et al., 2000; Dumont and Arteaga, 2000; Rossmanith and SchulteHermann, 2001; Grunert et al., 2003; Gotzmann et al., 2004) . With respect to hepatocellular carcinoma (HCC), overproduction of TGF-b and autocrine stimulation leading to elevated plasma levels in HCC patients correlate with poor prognosis (Ito et al., 1991; Shirai et al., 1994; Matsuzaki et al., 2000) .
Ras family proteins are key players in regulating cell homeostasis, and therefore have severe implications in most tumour types, when signalling in an oncogenic manner upon mutation or amplification. Ras exerts its signal through several downstream routes such as the Raf-Erk/MAPK and the phosphatidyl inositol 3 (PI3) kinase-PKB/Akt pathways, both representing the best studied ones. Several, in part, conflicting mechanisms have been described of how Ras can render cells insensitive to growth inhibition by TGF-b. Although TGF-b alone can be responsible for gross morphological changes occurring during EMT (Bhowmick et al., 2001 ), a cooperative proliferative stimulus is required to fully accomplish maintenance of the invasive phenotype (Janda et al., 2002; Grunert et al., 2003; Fischer et al., 2005) .
In the present study, we made use of the previously described, highly synchronous hepatocellular EMT in vitro to analyse the sequence of molecular events (Gotzmann et al., 2004) . Insights into the molecular changes during EMT were obtained by monitoring global expression patterns employing oligo-microarray analysis. Based on this expression profiling, a crucial role of the platelet-derived growth factor (PDGF) pathway was assumed, since PDGF-A ligand and PDGF receptor subunits were highly elevated upon EMT along with a TGF-b-induced secretion of PDGF-A. Indeed, interference with PDGF signalling indicated that this pathway is necessary and sufficient to stabilize the invasive phenotype during TGF-b-mediated hepatocellular tumour progression.
Results
Loss of cell-cell contacts is orchestrated in a hierarchical manner upon hepatocellular EMT We recently described a cellular model of late-stage hepatocarcinogenesis that involves the increase in malignancy of neoplastic hepatocytes towards the acquisition of metastatic properties. The change in cell fate of malignant hepatocytes has been characterized by an EMT transition arising from the synergism of TGF-b1 and hyperactive Ras signalling (Gotzmann et al., 2002) . By employing immortalized MMH-D3 hepatocytes (Amicone et al., 1997) , expression of oncogenic Ha-Ras (referred to as MMH-R) showed malignant transformation along with maintained epithelial characteristics. However, polarized MMH-R hepatocytes rapidly converted to spindle-shaped, fibroblastoid cells upon treatment with TGF-b1 and established an invasive phenotype after administration of TGF-b1 for more than 21 days (termed MMH-RT). Remarkably, fibroblastoid features could be observed as early as 12 h after TGF-b1 treatment, being morphologically completed within 24 h. Importantly, this change in epithelial cell plasticity occurred in a highly synchronous manner (Figure 1 ). The simultaneous conversion of malignant hepatocytes towards the metastatic phenotype encouraged us to investigate the molecular mechanisms underlying the sequential steps of EMT in a kinetic manner.
A prerequisite for acquiring a spindle-shaped cell type includes loss of cell polarity and adhesion. Comparison of epithelial MMH-R versus fibroblastoid MMH-RT cells revealed that EMT of hepatocytes is accompanied by cytoplasmic redistribution of the polarity marker ZO-1 as well as loss or redistribution of adherens junctions and desmosomal marker proteins such as E-cadherin, b-catenin, p120-catenin (p120 ctn ) and desmoplakin, respectively (Gotzmann et al., 2002) . Kinetic studies during the initial stages of EMT revealed that cytoplasmic accumulation of the tight junction protein ZO-1 preceded apparent changes of adherens junctions family members (Figure 1 ). Disintegration of tight junction complexes and thus loss of polarity started about 12 h after TGF-b1 addition (data not shown) and was nearly completed after 24 h. At this time, only few epitheloid cells retained membrane-associated staining for ZO-1. After 48 h, almost all cells displayed cytoplasmic distribution of ZO-1, as observed for p120 ctn . Likewise, the tumour suppressor E-cadherin was sparsely retained at cell-cell contacts after 24 h (Figure 1 ). An accumulation of E-cadherin in vesicle-like structures surrounding the nucleus was observed after 48 h. Prolonged treatment resulted in a continuous reduction of the E-cadherin immunostaining, which was hardly detectable after 3 days (data not shown). During initial stages of EMT, the majority of cells did not completely disintegrate their intercellular adhesion, since a high percentage of cells (>80%) still displayed membranelocalized b-catenin. A shift to a cytoplasmic distribution of b-catenin became detectable only after 7 days of TGF-b1 treatment (data not shown). In addition, the desmosomal constituent desmoplakin became distributed into the cytoplasm in a dot-like appearance between 24 and 48 h and was undetectable at later stages of EMT (data not shown). These data indicate that epithelial junctions get disintegrated in a hierarchical manner. Loss of polarity (tight junctions) appears to be a Figure 1 Disintegration of epithelial junctions during hepatocellular EMT. Phase-contrast and confocal immunofluorescence microscopy images after staining of cells with antibodies recognizing E-cadherin, ZO-1, b-catenin and p120 ctn , respectively. Images were taken from untreated MMH-R cells (0 h) and their fibroblastoid derivatives after administration of 2.5 ng/ml of TGF-b1 for 24 and 48 h, respectively. precondition for disintegration and remodelling of other junctional complexes such as desmosomes and adherens junctions, respectively.
The overall amount of the junctional proteins under investigation remained unchanged during the first 24 h, but progressively decreased after prolonged TGF-b1 treatment (Figure 2a) , suggesting that the cytoplasmic redistribution was accompanied by a decline in protein abundance. In accordance with immunofluorescence data, the expression of E-cadherin was sharply reduced after 3 days of TGF-b1 treatment, and the 100 kDa isoform of p120 ctn (Reynolds et al., 1996; Eger et al., 2000) was found to be stronger downregulated than the 120 kDa one. Similarly, reduced levels of b-catenin could be detected after 3 days of TGF-b1 treatment.
Recent data on transcriptional downregulation of E-cadherin during EMT (Batlle et al., 2000; Cano et al., 2000; Comijn et al., 2001; Poser et al., 2001) prompted us to analyse the fate of the transcriptional repressors Snail, SIP1 and delta-EF1. Interestingly, E-cadherin transcript levels were already sharply decreased 24 h post-TGF-b1 treatment, thus preceding the decrease in polypeptide expression (Figure 2b ). TGF-b1 treatment of MMH-R cells lead to a moderate upregulation of SIP1 transcripts, whereas the expression of Snail was induced immediately after cytokine treatment (Figure 2b ). Similarly, expression of delta-EF1 was rapidly elevated but decreased again to basal levels upon prolonged treatment with TGF-b1. The fast induction of delta-EF1 suggests it as a potential direct target gene of TGF-b signalling, resembling TGF-b-driven activation of Snail. These data propose that TGF-b is directly and critically involved in the transcriptional downregulation of E-cadherin and the concomitant loss of cell adhesion.
Unperturbed TGF-b signalling during hepatocellular EMT Ras transformation of MMH-D3 made cells refractory to the antiproliferative activity of TGF-b (Fischer et al., 2005) . The mechanism how Ras signalling might interfere with the proliferation arrest caused by the TGF-bSmad pathway, and instead, cooperates with TGF-b to induce EMT is still controversial (Hartsough and Mulder, 1995; de Caestecker et al., 1998; Kretzschmar et al., 1999; Yue and Mulder, 2000; Saha et al., 2001; Janda et al., 2002) . Thus, we addressed whether changes in Smad signalling, in particular nuclear translocation, in parental versus Ras-transformed MMH-R hepatocytes might account for the escape of growth arrest and the dramatic alterations in epithelial plasticity. After 4 h of TGF-b1 administration to MMH-R cells, Smad2, Smad3 and Smad4 shifted from a cytoplasmic to an almost unambiguous nuclear localization (Figure 2c ). When compared to parental MMH cells, no significant variations regarding the percentage or the kinetics of nuclear accumulation of Smads were observed (data not shown).
To further address Smad signalling at the transcriptional level, we performed luciferase reporter assays using constructs that can be specifically activated by Smad2 or Smad3. As shown in Figure 2d , the transactivation properties of both Smad2 (upper panel) and Smad3 (lower panel) remained unchanged irrespective of Ras transformation, although parental MMH-D3 hepatocytes undergo TGF-b-induced cell cycle inhibition and cell death (Gotzmann et al., 2002) . Together, these data indicate that the escape of Ras-transformed epithelial hepatocytes from tumour-suppressive functions of TGF-b and the acquisition of a fibroblastoid phenotype occurs without overt changes in TGF-b signalling upstream of Smad interactions with other transcription factors.
Specificity and redundancy of TGF-b family members in the induction of hepatocellular EMT By surveying the functional potential of TbR ligands and other growth factors as inducers of hepatocellular EMT, TGF-b2 and TGF-b3 revealed to be equally effective in executing changes in the plasticity of hepatocytes with kinetics highly comparable to those of TGF-b1 ( Figure 3 ). This observation was underlined by the fact that the immunofluorescence analyses of cells, stained for adhesion molecules as shown in Figure 1 , were in accordance with those obtained from TGF-b1 kinetics (data not shown). As found for TGF-b1, parental MMH-D3 cells responded to TGF-b2 and TGF-b3 with growth arrest in G1 and cell death (data not shown). TGF-b2 and TGF-b3 not only elicited nuclear translocation of Smad3 ( Figure 3a ) and Smad2 (data not shown) but also displayed comparable transactivation potential and kinetics of Smad3-and Smad2-responsive reporters ( Figure 3b and data not shown). In sharp contrast, activin bA was neither operative in mediating morphogenetic changes of MMH-R cells nor in activating Smad3 response (Figure 3b ), although RNase protection assays revealed that MMH-R cells expressed its cognate activin-like kinase receptors (data not shown). Likewise, members of the bone-morphogenetic protein (BMP) family such as BMP-4 and BMP-7 (administered at 200 or 500 ng/ml, respectively) were unable to elicit EMT, although they efficiently transactivated a BMP-specific reporter (data not shown). Other cytokines such as fibroblast growth factor (FGF)-1, FGF-2, insulin-like growth factor 1 (IGF-I), vascular endothelial growth factor (VEGF), PDGF-A, PDGF-B, and interleukin (IL)-3 failed to induce EMT of MMH-R hepatocytes, neither alone nor in combination (data not shown). Moreover, none of these cytokines and growth factors as well as none of the inducers of hepatocytic differentiation such as the synthetic glucocorticoid dexamethasone or IL-6 was able to inhibit hepatocellular EMT elicited by any of the three TGF-b isoforms (data not shown). These data clearly demonstrate that the induction of hepatocellular EMT can specifically be provoked by TGF-b1, TGF-b2 and TGF-b3, although a functional redundancy within these TGF-b ligands still persists.
Dynamic changes of gene expression upon hepatocellular EMT Expression profiling using microarray analysis was performed to obtain a more comprehensive insight into the molecular changes occurring upon hepatocellular EMT. Polysome-bound transcripts were used for comparative hybridization on Affymetrix GeneChips TM containing about 11 000 genes. This approach is superior to identify changes in actively translated mRNA populations by eliminating RNA pools not translated and therefore not representative for the proteome (Mikulits et al., 2000; Pradet-Balade et al., 2001) . RNA fractions were prepared from MMH-R cells treated with TGF-b1 for 24, 72 or 120 h, respectively, and screened against polysome-associated mRNA pools of untreated MMH-R cells as a reference.
By considering transcript levels induced >2.0-fold or repressed o0.5-fold as significant, we identified in total 917 regulated genes including 313 known genes and 604
(not yet classified) expressed sequence tags (163 upregulated; 441 downregulated). To allow functional classification of regulated genes, we focused on known genes for cluster analysis. The majority of transcripts corresponding to characterized proteins was downregulated (235; 75%), whereas 78 (25%) genes were upregulated in kinetics of hepatocellular EMT. Noteworthy, most of the altered transcripts were strongest regulated 24 h post-TGF-b1 treatment of MMH-R hepatocytes. In order to get a plain overview of the molecular changes during EMT, all differentially regulated genes were arranged into functional subgroups and clustered within their specific characteristics (Figures 4 and 5; whole expression data in tables are available upon request).
In accordance with the morphological changes during EMT, essential genes participating in intercellular adhesion were downregulated, such as the adherens junction components E-cadherin and b-catenin as well as the gap junction proteins connexin-30.3 and connexin-43 (Jiang et al., 1995; Cai et al., 1998) (Figure 4 ; see also Figure 2a and b). Furthermore, the adhesion molecules N-CAM (neuronal cell adhesion molecule), plakophilin-1 and N-cadherin became upregulated upon ongoing EMT. Interestingly, N-cadherin, which is also dedicated as mesenchymal cadherin, has been shown to behave as a weak intercellular adhesion component in cells devoid of E-cadherin (Bhowmick et al., 2001) and to even enhance the malignant phenotype (Hazan et al., 2000) .
The interactions between cancer cells and their microenvironment create a context promoting tumour growth, cell invasiveness, metastasis and protection from immune surveillance. Genes remodelling the ECM involved upregulated TGF-b target genes of the collagen family such as Col5A2, Col4A1, Col4A2, Col1A1 and Col3A1 (Verrecchia et al., 2001) as well as fibronectin and tenascin during the first 120 h of hepatocellular EMT. In contrast, the differentiation markers SPRR1a and involucrin were substantially (>5-fold) reduced. In agreement with the acquisition of an invasive phenotype upon EMT, we observed upregulation of ECM remodelling enzymes, such as plasminogen activator inhibitor-1 and the MMP inhibitor TIMP-3. Induction of the TGF-b induced protease furin, which converts latent TGF-b to an active cytokine (Dubois et al., 2001) , may contribute to the maintenance of the autocrine TGF-b loop. Furthermore, Ly6a.2, a cell surface marker particularly enriched on metastatic cells (Witz, 2000) , was sharply increased (>50-fold) after prolonged TGFb1 treatment. Changes in integrin patterning displayed upregulation of the fibronectin receptor subunit integrin b1 and the concerted decrease of the parenchymalenriched isoform integrin b4. Hepatocellular EMT is accompanied by extensive reprogramming of the cytoskeleton, primarily of the actin polymer framework (Gotzmann et al., 2002) . In line with these recent findings, genes for actin-associated (e.g. profilin) and actin-capping (capping protein a2) proteins were found downregulated, as observed for the typical epithelial framework constituents cytokeratin (CK)-19 and CK-15, respectively ( Figure 4 ). In addition, transcripts of the hepatic myofibroblastoid marker proteins fibulin-2 and a-smooth muscle actin were highly increased (Knittel et al., 1999; Tsuda et al., 2001; Proell et al., 2005) .
The majority of regulated known genes belong to the class of transcription factors. Increased expression was monitored for Snail (see also Figure 2b ) and for the orphanic receptor Coup-TF1, which is involved in a variety of developmental processes. The dedifferentiation of hepatocytes was reflected by downregulation of the liver-enriched hepatocyte nuclear factor (HNF)-3b. As already observed, the transcript of the immediate early upregulated c-fos was vigorously decreased 24 h after induction of EMT, which indicates mandatory repression of the antiproliferative activity provided by c-fos in hepatocytes (Mikula et al., 2003) . The circumvention of triggering cell death is reconciled by downregulation of proapoptotic factors such as c-myc and Eya-2.
A special attention in the evaluation of expression profiling was put on cytokines and growth factors. Interestingly, the expression of TGF-b3, which has been shown to induce hepatocellular EMT (Figure 3 ), was increased with prolonged TGF-b1 administration (Figure 4) . Upregulation of TGF-b3, which occurs by translational control (J Gotzmann et al., unpublished data), might signal in an autocrine manner and thus contributes to the maintenance of the invasive mesenchymal phenotype, as already shown for TGF-b1 (Gotzmann et al., 2002) . An explanation for the failure of activin-bA to induce EMT of the MMH-R cells (Figure 3b ) might rely on the increase of transcripts of both subtypes of inhibin-b, functionally antagonizing inhibition of liver cell growth by activins in a dominantnegative (dn) manner (Xu et al., 1995) . The upregulation of inhibin-bA was relatively constant (3.6-4.6-fold) between 24 and 120 h of TGF-b1 treatment, whereas the B-subunit was highly activated at 72 h (9.4-fold) with increased expression after long-term treatment (52-fold in established MMH-RT cells versus MMH-R hepatocytes; J Gotzmann et al., unpublished data). The angiogenesis-promoting potential of mesenchymal derivatives is represented by the increased expression of proangiogenic endothelin-1, a crucial cytokine in the complex interplay of neovascularization in metastatic MMH-RT-derived tumours.
Establishment of an autocrine PDGF loop during hepatocellular EMT Kinetic profiling of hepatocellular EMT revealed induced expression of genes involved in PDGF signalling. In particular, PDGF-A transcripts were found highly elevated and forced expression of PDGF-inducible genes encoding the chemokines MCP-1 and KC was monitored ( Figure 5 ). Therefore, semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to analyse the expression of components directly involved in this signalling cascade by employing EMT kinetics and established fibroblastoid MMH-RT cells (Figure 6a ). These data confirmed results of microarray analysis, showing a sharp expression peak of PDGF-A at 24 h, which subsequently declined to lower levels at 120 h as compared to the MMH-R reference. A comparable, although fluctuating, upregulated expression of PDGF-a and -b receptors was detected, being highest at 24 h after TGF-b1 treatment and in established MMH-RT cells (Figure 6a ). These data on PDGF-a and -b receptor expression during TGF-b1 kinetics could be confirmed at the protein level as analysed by immunoblotting (Figure 6b ).
The bioactivity of PDGF secreted by MMH-R and MMH-RT cells was analysed by employing murine FDCP cells expressing human PDGFR-a receptor (von Ruden and Wagner, 1988) , which proliferate in a strict PDGF-responsive manner (Figure 6c ). Thymidine incorporation assays revealed that fibroblastoid MMH-RT cells, in contrast to epithelial MMH-R cells, secrete amounts of PDGF that significantly induced DNA synthesis rates of FDCP cells, similar to stimulation of proliferation by fetal calf serum (FCS) or recombinant PDGF. Moreover, a neutralizing antibody to PDGF-A -functionally interfering with PDGF-R signallingreduced the proliferation-inducing activity of fibroblastoid MMH-RT supernatants to basal levels shown by epithelial control supernatants, thus demonstrating that MMH-RT secrete bioactive PDGF. From these data we concluded that the cooperative signalling of Ha-Ras and TGF-b induces autocrine regulation of PDGF-A in invasive hepatocytes.
Interference with PDGF signalling decreases cell migration and suppresses tumour formation In order to verify and investigate the importance of PDGF signalling, we made use of a recently developed, more physiological murine hepatocellular EMT model based on immortalized p19 ARF null hepatocytes that have been referred to as MIM . The established MIM hepatocytes show a highly differentiated, polarized phenotype, express liver-specific markers, are nontumorigenic and revealed liver reconstituting activity after intrasplenic transplantation into Fas-injured livers of SCID mice . As shown for MMH hepatocytes, MIM cells were able to undergo EMT upon the collaboration of hyperactive Ha-Ras and TGF-b (Fischer et al., 2005) . Importantly, the induction of PDGF-A ligand and PDGF-a and -b receptors in TGF-b-treated MIM-R hepatocytes was identical to that observed in MMH-R-cells (compare Figure 6a and Figure 7a ). These data demonstrate that the activation of PDGF components during hepatocellular EMT is independent of the genetic background. To obtain genetic evidence for a potential crucial function of PDGF, interference with PDGF signalling was achieved through bicistronic expression of a dn mutant of the PDGF-a receptor (Yu et al., 2000) and red fluorescent protein (RFP) in MIM-R hepatocytes (Figure 7c ). The functionality of the dn construct in inhibiting the signalling of PDGF-a receptor has already been tested and verified in a variety of cell lines (Yu et al., 2000 (Yu et al., , 2003 . The resulting cells, termed MIM-RPDGFdn, were enriched in only about 80% RFP-positive cells even after two rounds of cell sorting, and showed proliferation kinetics comparable to those of MIM-R hepatocytes in vitro (Figure 7b and data not shown).
MIM-R-PDGFdn as well as MIM-R hepatocytes, respectively, were analysed for their migratory abilities by employing wound-healing assays. Immediately after setting the 'wound' in the confluent monolayer, cells were induced to EMT by administration of 2.5 ng/ml TGF-b1. After 48 h, MIM-R cells revealed complete closure of the scratch, whereas MIM-PDGFdn cells were markedly impaired in migration (Figure 8a) . Comparable results were obtained after treatment of both cell types with either TGF-b2 or TGF-b3 (data not shown). In line with these observations, pharmacological interference with each TGF-b signalling using SB-431542, and PDGF signalling, employing either the neutralizing antibody for PDGF or the low molecular weight compound STI571, efficiently inhibited the wound closure of MIM-R hepatocytes treated with TGF-b (data not shown).
As recently reported, TGF-b1 pretreatment prior to subcutaneous injections of the cells caused an increase in malignancy resulting in vast tumour formation (Gotzmann et al., 2002) . To investigate the effect of PDGF signalling on the tumorigenic potential, MIM-R and Figure 4 Cluster analysis and functional classification of the expression profile of hepatocellular EMT kinetics. The diagrams represent the results of hierarchical clustering using a set of genes significantly altered during hepatocellular EMT. Prefiltering criteria required transcript levels to be altered at least two-fold or 0.5-fold at one of the three time points. Shown is a coloured representation of expression data of annotated genes (no ESTs) with the rows (genes) and columns in cluster order (from left to right: 1st column, MMH-R treated with 2.5 ng/ml TGF-b1 for 24 h compared to untreated MMH-R; 2nd column, 72 h TGF-b1 treatment of MMH-R compared to untreated MMH-R; 3rd column, 120 h TGF-b1 treatment of MMH-R compared to untreated MMH-R). The colour scale inserted represents fold up-(red) and downregulation (blue) of genes as indicated by the vertical numbering. The dendrogram at the left side of the panels represents hierarchical relationships between the genes altered. were treated with serum-free tissue culture supernatants from MMH-R (grey bars) and MMH-RT (black bars) cells. As positive control, the mitogenic activity was measured by including either supplementation of 10% FCS (FCS) or 2.5 ng/ml of recombinant human PDGF-A/B (PDGF), respectively (white bars). Serum-starved cells served as a negative control. To check the specificity of the proliferative response, a PDGF-A-selective neutralizing antibody (NA) was added at a concentration of 20 mg/ml.
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and d) rather than a previously reported inhibition of Smad transactivation by the Ras-Raf-Mek-Erk pathway (Kretzschmar et al., 1999) has been shown to be essential to confer resistance of cells towards TGF-bmediated growth arrest and cell death (Gotzmann et al., 2002; Fischer et al., 2005) . In this study, we therefore focused on the cooperative, tumour-promoting functions of TGF-b-and Ras signalling during hepatocarcinogenesis by identifying critical regulators using microarrays and corresponding functional analysis. Firstly, we demonstrate that in cooperation with Ha-Ras all three isoforms of TGF-b cytokines were equally effective in inducing EMT, in sharp contrast to other, noneffective members of the TGF-b superfamily, like activin-bA, BMP-4 and BMP-7, respectively. Accordingly, Valcourt et al. (2005) found that the three TGF-b isoforms induced EMT in mammary and lung epithelial cell lines, while displaying a less pronounced morphogenic trigger on keratinocyte lineages. Moreover, activin-bA could only elicit scattering in lung epithelial cells, remaining ineffective in the other cells. This observation has been explained by a lack of transactivation of Smad2 target genes (Valcourt et al., 2005) . Similarly, our data show that activin-bA failed to transactivate Smad3-responsive reporter elements (Figure 3b) . Ligands of the BMP family completely lacked morphogenic functions, as shown for BMP-7 on various cell types (Valcourt et al., 2005) . Taken together, the induction of EMT might not only be specific within the TGF-b superfamily of cytokines but is indicated to be cell type specific, too.
Despite the specificity within this superfamily of cytokines, a broad spectrum of other ligands (VEGF, PDGF, FGF-1, IL-6, IL-3, IGF-1, HGF, EGF) remained inoperative in eliciting hepatocellular EMT (Figure 3 and data not shown), although some of them have been shown to induce EMT-like characteristics in other cell systems (Gotzmann et al., 2004) . Noteworthy, TGF-binduced factors, which are involved in autocrine regulation and are considered to be essential for survival of mesenchymal cell types, fail to act as morphogens (VEGF; Bates et al., 2003) .
Investigating the sequence of morphological alterations in MMH hepatocytes upon EMT revealed that loss of epithelial polarity preceded -and thus appears to be a precondition for -remodelling or disintegration of adhesion and desmosomal junctions, respectively (Figure 1) . Transient upregulation of E-cadherin repressors mirrored the kinetics of the cytoplasmic distribution of the tumour suppressor E-cadherin as well as the downregulation of its transcript and protein levels, respectively. SIP1 and Snail have so far been identified as direct TGF-b target genes (Peinado et al., 2003; Zavadil et al., 2004) , while Snail and delta-EF1 additionally have been shown to mediate EMT upon ectopic expression by repressing E-cadherin (Batlle et al., 2000; Cano et al., 2000; Eger et al., 2005) . The importance of Snail is further emphasized by the fact that Snail knockout mice die early and show defects in EMT during embryonic development (Carver et al., 2001) . Moreover, SIP1 and delta-EF1 could still act autonomously or in concert with Snail to mediate transcriptional repression of E-cadherin. On the other hand, we observed a sharp reduction in the expression level of WT1 (data not shown), a zinc-finger protein associated with Wilms' tumour, which has recently been demonstrated to be a direct enhancer of E-cadherin expression (Hosono et al., 2000) . Therefore, we conclude that a complex interplay of transcription factors and associated molecules is instrumental in regulating most cell adhesion properties in the transition from an EMT phenotype in hepatocytes. Disintegration of membranelocalized b-catenin and redistribution to the cytoplasm was found to be a late event in vitro (Figures 1 and 2 ), which might facilitate or be accounted as a precondition for nuclear translocation of b-catenin, as observed in experimental tumours arising from MIM-RT cells (M Mikula et al., unpublished observation) .
A variety of expression profiling approaches have been conducted to evaluate target genes for TGF-b (Verrecchia et al., 2001; Zavadil et al., 2001; Coyle et al., 2003; Valcourt et al., 2005) . In our survey of molecular events in hepatocellular EMT, we took advantage of screening the 'active' transcriptome by hybridization of polysome-bound mRNA populations (Mikulits et al., 2000; Pradet-Balade et al., 2001) . The three time points selected covered (i) 24 h TGF-b1 treatment, characterized by the induction of Erk signalling and loss of polarity, (ii) 72 h post-TGF-b1 treatment representing start of the maintenance phase by upregulation of PI3 kinase, and (iii) 120 h TGF-b1 treatment when EMT is essentially completed including adhesive reprogramming (Figures 4 and 5) .
Based on these expression profiling data, a crucial role of the PDGF signalling pathway was deduced, since transcripts encoding PDGF-A ligand and both PDGF receptor subunits were found to be highly elevated upon EMT. According to previous reports that TGF-b induces PDGF-A expression without significantly affecting transcripts for PDGF-B, this ligand was found unchanged in our hepatocellular tumour model (Paulsson et al., 1988; Soma and Grotendorst, 1989) . Similar upregulation of the entire PDGF signalling pathway was found by expression profiling of Ras-TGFb-induced EMT in the mammary epithelial cell model EpH4/EpRas . PDGF signalling stimulates various signalling pathways including Ras-MAP kinase, the PI3 kinase, the phospholipase C-g, the cytoplasmic tyrosine kinase c-Src and different Stats (Heldin et al., 1998) . Actually, the classical Ras/MAP kinase signalling induced by PDGF has been assigned not only to proliferation but, most interestingly, also to metastasis (MacDonald et al., 2001) , whereas the PDGF-mediated PI3 kinase activation has been found to exert its effects by protection from apoptosis (Barres et al., 1992; Yao and Cooper, 1995) . Dysregulation of PDGF ligands and receptors has been found in a variety of diseases such as developmental defects, inflammation, fibrosis and cancer (Heldin and Westermark, 1999) . In almost all of these disorders, either the receptors were found to be upregulated or mutated, keeping them constitutively active, or cells within the affected tissue produce PDGF ligands for which they carry the corresponding receptor. The coexpression of PDGF and PDGF receptors suggests an autocrine growth stimulation that has been reported in a considerable number of solid tumours, including gliomas, meningiomas, melanomas, neuroendocrine tumours and carcinomas of the prostate, breast, lung, stomach and pancreas (Ostman and Heldin, 2001) . Accordingly, inhibition of the PDGF pathway by imatinib mesylate (also known as STI571 or Gleevec) has entered clinical trials and has already been proved to be successful in therapy of gastrointestinal stromal tumours, brain tumours, prostate cancer and chronic myelogenous leukaemia (Kilic et al., 2000; George, PDGF in hepatocarcinogenesis J Gotzmann et al Newton, 2003; Deininger, 2004) . Noteworthy, imatinib mesylate is a competitive inhibitor of a few tyrosine kinases, including BCR-ABL, c-ABL and c-KIT, in addition to PDGF receptors (George, 2001; Joensuu and Dimitrijevic, 2001) .
With regard to liver diseases that give rise to hepatocellular cancer, it is of particular interest that PDGF has been implicated in liver injury and liver cirrhosis (Heldin et al., 1991; Pinzani et al., 1994; Pinzani et al., 1996) . In addition, analyses of human HCCs showed a strongly enhanced expression of PDGF receptors in cancerous liver tissue compared to normal liver but not of the corresponding cytokines themselves (Tsou et al., 1998; Xu et al., 2001; Chen et al., 2002 ). Yet, the functional implication of PDGF activation in human HCC is poorly understood and remains to be elucidated.
Here, we show first evidence that autocrine secretion of PDGF-A is induced in TGF-b-mediated liver tumorigenesis. This could be confirmed by employing two different murine models, based on MMH and on MIM immortalized hepatocytes, respectively, indicating independence of the genetic background. Most interestingly, simultaneous blockade of EGF-R and PDGF-R phosphorylation coupled with the administration of paclitaxel induced apoptosis in tumour-associated endothelial cells and significantly suppressed bone metastasis in human prostate cancer patients (Uehara et al., 2003; Kim et al., 2004) . Thus, activation of EGF-R and PDGF-R, both preferentially signalling via Ras, plays a crucial role in migration and generation of the tumour vasculature in prostate cancer and probably as well in HCCs. In Ras-transformed MIM hepatocytes, interference with PDGF signalling through expression of a dn mutant of the PDGF-a receptor strongly reduced tumour growth and selected for loss of dn PDGF-a receptor expression. This suggested an essential, probably cell-autonomous contribution of PDGF to the migratory phenotype during TGF-b-mediated hepatocellular late-stage tumour progression. PDGF has been reported to provide migratory abilities through stimulating members of the rho family of small GTP-binding proteins (Hawkins et al., 1995; Hooshmand-Rad et al., 1997; Rodriguez-Viciana et al., 1997) . Cooperation of Erk signalling, which is necessary for proliferation and survival of cells during hepatocellular EMT (Fischer et al., 2005) , and the PDGF pathway has been shown to be a prerequisite for phosphorylation efficiency of FAK, and thus, for enhancing the migration capability (Carloni et al., 2001) . Moreover, a direct cooperation between PDGF and integrins has been demonstrated, which enhances cell motility and prevention of apoptosis as well as the modulation of the ECM (Sundberg and Rubin, 1996; Schneller et al., 1997; Bissell and Radisky, 2001) . It is further tempting to speculate that the remodelling of ECM, allowing or enhancing cell movement, is cooperatively driven by autocrine TGF-b and PDGF regulation. In this respect, PDGF is known to play an important role in wound healing by stimulating the production of several matrix molecules such as fibronectin, collagen, proteoglycans and hyaluronic acid. At later stages of wound healing, PDGF stimulates the production and secretion of collagenase by fibroblasts (Heldin and Westermark, 1999) . Similar to the function of VEGF, PDGF has been shown to be operative as an angiogenic factor, which promotes vascularization of tumours (Risau et al., 1992; Battegay et al., 1994) .
Taken together, our data indicate a crucial role of the PDGF/PDGF-R pathway in supporting tumour progression as well as in promoting motile characteristics of hepatocytes undergoing EMT, thereby maintaining its activity in an autocrine manner. Further functional analyses of PDGF in hepatocellular EMT models will reveal its impact in hepatocarcinogenesis and will contribute to the development of novel auspicious strategies for anticancer therapy.
Materials and methods
Cell culture
Immortalized Met murine hepatocytes (MMH-D3), and those derived from p19 ARF null hepatocytes, termed MIM1-4, were cultured on rat tail collagen-coated dishes in RPMI 1640 supplemented with 10% FCS, 40 ng/ml recombinant human TGF-a (Sigma, St Louis, USA), 30 ng/ml recombinant human insulin-like growth factor II (IGF-II, Sigma, St Louis, USA), 1.4 nM insulin (Sigma, St Louis, USA) and antibiotics. MMH-R and MIM-R hepatocytes were generated by retroviral transmission of parental MMH-D3 and MIM1-4 cells with a vector bicistronically expressing constitutive active v-Ha-Ras plus green fluorescent protein (GFP), respectively, and were grown in RPMI 1640 supplemented with 10% FCS and antibiotics (Oft et al., 1996) . Fibroblastoid derivatives of MMH-R cells, termed MMH-RT, were propagated in RPMI 1640 plus 15% FCS, 1 ng/ml recombinant human TGF-b1 (R&D Systems, Minneapolis, USA) and antibiotics as outlined recently (Gotzmann et al., 2002) . MIM-R-dnPDGF cells resulting from the stable retroviral transmission of MIM-R hepatocytes with pMSCV-dnPDGF-Ra-red, harbouring red fluorescent protein (RFP), were cultured as described for MIM-R cells. All cells were kept at 371C and 5% CO 2 and routinely screened for the absence of mycoplasma.
Rat tail collagen was prepared as described (Ehrmann and Gey, 1956) . Recombinant human TGF-b1, TGF-b2, TGF-b3, PDGF-A/B, activin bA, and BMP-4 and -7 (all purchased from R&D Systems, Abingdon, UK) were used at concentrations indicated in the text.
Vector cloning
For construction of the pMSCV-dnPDGF-Ra-red vector allowing bicistronic expression of dnPDGF-Ra and RFP, a BglII and HindIII fragment of pGK obtained from pMSCVgfp (Clontech, Palo Alto, USA) was ligated into pDsRed-N1 (Clontech, Palo Alto, USA). The resulting plasmid pGKDsRed-N1 was cut with BglII and NotI and blunted to receive the pGKred fragment. The pGKpuro cassette of pMSCV-puro (Clontech, Palo Alto, USA) was further replaced by the pGKred fragment after cutting and blunting BglII and ClaI sites to obtain a pMSCV-red vector (Hawley et al., 2001) . pMSCV-red was modified to work as destination vector for Gateway TM cloning (Invitrogen, Carlsbad, CA, USA) after ligation of the conversion cassette (RFB, EcoRV) into pMSCV-red (HpaI). The dnPDGF-Ra cDNA was amplified by PCR using primers containing the attL sites as template from the vector pcDNAI/Neo (Yu et al., 2000) . The dnPDGFRa cDNA was inserted into the pMSCV-RFB by LR reaction using the Gateway TM technology, resulting in the vector pMSCV-dnPDGF-Ra-red.
Confocal immunofluorescence microscopy
Cells grown on filters (Falcon 353090, Becton Dickinson, Franklin Lakes, USA) or on poly-L-lysine-coated coverslips (Sigma, St Louis, USA) were processed for immunological detection as described recently (Gotzmann et al., 2002) . Dilutions of primary antibodies used are as follows: anti-Ecadherin (Transduction Laboratories (TL), Lexington, UK), 1:100; anti-b-catenin (TL), 1:125; anti-p120 ctn (TL), 1:200; antiSmad2 (TL), 1:250; and anti-ZO-1 (Zymed Laboratories, South San Francisco, USA), 1:75. Rabbit sera directed against Smad2, Smad3 and Smad4 (1:50) were a kind gift of Dr Peter ten Dijke, The Netherlands Cancer Institute, Amsterdam, The Netherlands (Nakao et al., 1997) . After application of cye-dyeconjugated secondary antibodies (Jackson Laboratories, WestGrove, USA), cells were imaged with the TCS-SP confocal microscope (Leica, Heidelberg, Germany). Conventional microscopy of cells was performed with a Nikon Eclipse TE300 inverted light microscope (Nikon Corporation, Tokyo, Japan). Since cells themselves show fluorescence due to GFP expression, some microscopic images were pseudo-coloured green or red in silico for proper illustration.
Reverse transcription-polymerase chain reaction Poly(A) þ mRNA was extracted and reverse transcribed employing a mRNA isolation and first-strand cDNA synthesis kit (Roche Diagnostics, Mannheim, Germany). Aliquots of the resulting products were used as templates for specific PCR amplification using Ready-To-Go PCR beads (Amersham Pharmacia Biotech, Uppsala, Sweden), as outlined recently (Gotzmann et al., 2002) . The conditions for PCR reaction were optimized for each primer pair. The following forward and reverse primer were used for specific amplification, respectively: E-cadherin -5
0 . The amplification products were analysed by electrophoresis on 1% agarose gels and staining with ethidium bromide.
Immunoblotting
The preparation of cellular extracts, separation of proteins by SDS-polyacrylamide gel electrophoresis, and immunoblotting were performed as described recently (Gotzmann et al., 2002) . Immunological detection of proteins was performed with the SuperSignal detection system (Pierce Chemical Company, Rockford, USA). The primary antibodies were used at the dilutions: anti-E-cadherin (Transduction Laboratories (TL), Lexington, UK), 1:3000; anti-b-catenin (TL), 1:1000; antip120 ctn (TL), 1:2000; anti-ZO-1 (Zymed Laboratories, South San Francisco, USA), 1:1500; anti-PDGF-aR (Santa Cruz Biotechnology, Santa Cruz, USA), 1:1000; anti-PDGF-bR (Neomarkers, Freemont, USA), 1:1000; and anti-actin (Sigma, St Louis, USA), 1:2500. Horseradish peroxidase-conjugated secondary antibodies (Calbiochem, LaJolla, USA) were used at dilutions of 1:10 000.
Transient transfections and reporter gene assays MMH-D3 or MMH-R cells were plated at a density of 5 Â 10 4 cells per 12-well plate 1 day before transfection. Lipofectamine Plus was used for transient transfections, as recommended by the manufacturer (Invitrogen, Carlsbad, USA). To analyse the transcriptional response mediated by Smad2 (Germain et al., 2000) , cells were cotransfected with a luciferase reporter linked to the distal element of goosecoid (DE; a kind gift of Carol Hill, Imperial Cancer Research Fund, London, UK), the Smad2 coactivator Mixer and a b-galactosidase reporter (Eger et al., 2000) . Smad3-dependent transactivation was determined by cotransfection of cells with (CAGA)12-Luc, containing concatemeric Smad3 consensus binding sites (Dennler et al., 1998) , and b-galactosidase reporter. After cell lysis, the luciferase activity was determined by a Luminoskan (Labsystems, Farnborough, UK) as described previously (Mikula et al., 2003) . All assays were performed in triplicate and results represent the average of three independent experiments after normalization to b-galactosidase activities.
RNA isolation and microarray analysis
Polysome-associated mRNA populations were isolated through fractionation of cytoplasmic extracts in sucrose gradients as described (Mikulits et al., 2000) . Briefly, cellular extracts were prepared and supplemented with dithiothreitol, cycloheximide, heparin and phenylmethylsulfonyl fluoride after removal of nuclei and mitochondria. The resulting supernatants were layered onto 10 ml linear sucrose gradients (15-40% sucrose (w/v)) and centrifuged in an SW41Ti rotor (Beckman, Palo Alto, USA) at 38 000 r.p.m. for 120 min at 41C. The RNA extracted from 19 harvested fractions were subsequently analysed for integrity and association with (poly)ribosomes (Mikulits et al., 2000) . Fractions 12-19 of each sucrose gradient containing polysome-associated RNA were pooled and poly(A) þ mRNA were isolated quantitatively using Oligotex-dT beads (Qiagen, Hilden, Germany). Each cRNA preparation for hybridization was performed with 5 mg of polysome-bound RNA, according to the protocol provided by Affymetrix, Santa Clara, USA (Wodicka et al., 1997; Mahadevappa and Warrington, 1999) . RNA labelled by incorporation of biotinylated CTP and UTP was purified with RNeasy columns (Qiagen, Hilden, Germany) and quantified by a spectrophotometer. Affymetrix Mu11K GeneChips consisting of two individual subarrays (subA and subB), in total containing roughly 11 000 probe sets of oligonucleotides, were subsequently hybridized at 451C for 16 h. Following washes, probe arrays were scanned three times at 6 mm resolution using the GeneChip system confocal scanner (Hewlett-Packard, Waldbronn, Germany). GeneChip 3.0 (Affymetrix, Santa Clara, USA) was used to scan and quantitatively analyse the scanned image. To correct for minor differences in overall chip fluorescence, intensity values were scaled to a level that the overall fluorescence intensity of each chip of the same type was equivalent. Genes induced >2.0-fold or repressed o0.5-fold versus baseline has been considered as significantly regulated and included into interpretation. In EMT kinetics, only those genes displaying significant changes to reference at least at one time point were recorded.
Analysis of PDGF secretion
Mouse hematopoietic FDCP cells exogenously expressing the human PDGF-a receptor were employed to analyse bioactive PDGF-a in tissue culture supernatants (von Ruden and Wagner, 1988). MMH-R and MMH-RT cells were grown in serum-free RPMI for 48 h, and PDGF-responsive FDCP cells were cultured in RPMI supplemented with 2 ng/ml IL-3 (R&D Systems, Abingdon, UK) for 24 h. Supernatants of MMH-R and MMH-RT cells were added to serum-starved FDCP cells for 20 h. As indicated, a neutralizing anti-PDGF-A antibody (R&D Systems, Abingdon, UK) was employed to interfere specifically with PDGF-A-mediated signalling. To monitor DNA synthesis rates, cells were pulsed with 1 mCi [ 3 H]thymidine (ICN, Irvine, USA) for 2 h (Mikula et al., 2003) , harvested on glass-fibre filters (Packard, Meriden, USA), and the radioactivity associated with DNA was determined in a microplate scintillation counter (Packard, Meriden, USA). All assays were performed twice in triplicate measurements, and the values determined represent the average of counts (c.p.m.).
In vitro wound healing assay Cells were seeded in six-well culture dishes to grow until confluence. Subsequently, a wound was incised by scratching a path with sterile pipette tips through the confluent layer of cells. The detached cells were removed by careful washing, before adding fresh culture medium supplemented with either 2.5 ng/ml of TGF-b1, TGF-b2 or TGF-b3. For inhibition of signalling pathways, the low molecular weight compounds SB-431542 (Inman et al., 2002) and STI571 (a kind gift of Novartis Pharma KG, Basel, Switzerland; Kilic et al., 2000) were added to the culture medium at concentrations of 10 mM, whereas PDGF-A-selective neutralizing antibody was used at a concentration of 20 mg/ml. After 24 and 48 h, cells migrating into the wound were monitored by phase-contrast microscopy (Cano et al., 2000) .
Tumour formation in vivo Cells of the desired cell type were detached from the tissue culture plate, washed with phosphate-buffered saline and resuspended in Ringer solution. Subsequently, aliquots of 1 Â 10 6 cells in 100 ml Ringer solution were each subcutaneously injected into three immunodeficient SCID/BALB/c recipient mice. Tumour formation was measured periodically by palpation, and the tumour size was determined using a vernier caliper. Tumour volume was calculated from tumour size using the formula diameter Â diameter Â length/2, as described recently (Gotzmann et al., 2002) . All experiments were performed twice in triplicate and carried out according to the Austrian guidelines for animal care and protection.
